Latigo Biotherapeutics, Inc.

Biotechnology ResearchThousand Oaks, California, United StatesFounded 201862 employees$300M raised

Latigo Biotherapeutics is a clinical-stage biotech developing non-opioid pain treatments, with $300M in funding. Its lead candidate LTG-001 targets acute pain by inhibiting Nav1.8 signals.

Employees
62
Total raised
$300M
Last: Series B
Open roles
1
0% vs last year
Site visitors
5K
per month
Alumni founders

The growth story

Latigo Biotherapeutics, Inc. headcount and funding62 people today
62$135M$150M6220222023202420252026
Data by CrustdataCrustdata

Latigo Biotherapeutics, Inc. grew from 17 to 62 employees between 2022 and 2026, raising $300M along the way, most recently a Series B in March 2025.

About

Latigo develops oral drugs that block pain transmission without opioid addiction risks. Its pipeline focuses on selective sodium channel inhibitors, initially targeting acute pain conditions.

The company raised $300M in Series B funding in March 2025, backed by firms like 5AM Ventures and Blue Owl. With 62 employees, it operates in Thousand Oaks near major biotech hubs.

Founders and leadership

Operations is the largest department with 8 employees. The leadership team comes from Amgen and other California biotechs, with median tenure of 2 years.

The Latigo Biotherapeutics, Inc. org chart

Nima Farzan (Chief Executive Officer) leads 37 mapped leaders with 3 direct reports. Click +N to expand a team; names link to the person’s public profile.

  • Chief Executive Officer
    CEO
    • Senior Executive Business Partner to the CEO & CFO/CBO | Strategic Operations
      Executive
    • Chief Medical Officer
      Executive
    • Chief Financial Officer & Chief Business Officer
      Executive

Departments, and which ones grew

Headcount by functiongrowth vs 12 months ago
RResearch
21+17%
BBusiness Development
13+63%
OOperations
5+67%
CCommunity and Social Services
3+50%
LLegal
3+50%
Data by CrustdataCrustdata

Headcount by function: Research 21 (+17% YoY), Business Development 13 (+63% YoY), Operations 5 (+67% YoY), Community and Social Services 3 (+50% YoY), Legal 3 (+50% YoY).

Talent flow

Nearly 20% of employees previously worked at Amgen. Other common sources include Kinnate Biopharma and Gilead Sciences. Alumni have moved to Kite Pharma and Revolution Medicines.

Where Latigo Biotherapeutics, Inc. people come from, and where they go47 current + 19 former profiles
9 people: Amgen → Latigo Biotherapeutics, Inc.6 people: Kinnate Biopharma → Latigo Biotherapeutics, Inc.3 people: AtaiBeckley → Latigo Biotherapeutics, Inc.3 people: PaxVax → Latigo Biotherapeutics, Inc.3 people: Gilead Sciences → Latigo Biotherapeutics, Inc.3 people: Rho → Latigo Biotherapeutics, Inc.2 people: Chief → Latigo Biotherapeutics, Inc.2 people: Novartis → Latigo Biotherapeutics, Inc.2 people: Latigo Biotherapeutics, Inc. → Kite Pharma1 people: Latigo Biotherapeutics, Inc. → Modulo Bio1 people: Latigo Biotherapeutics, Inc. → Kailera Therapeutics1 people: Latigo Biotherapeutics, Inc. → Revolution Medicines1 people: Latigo Biotherapeutics, Inc. → 5AM Ventures1 people: Latigo Biotherapeutics, Inc. → Sundance Biosciences1 people: Latigo Biotherapeutics, Inc. → Westlake BioPartners®1 people: Latigo Biotherapeutics, Inc. → Ronald McDonald House Charities of SoCal (RMHCSC)Latigo Biotherapeutics, Inc.62 peopleCAME FROMWENT TOAmgen9 peopleKinnate Biopharma6 peopleAtaiBeckley3 peoplePaxVax3 peopleGilead Sciences3 peopleRho3 peopleChief2 peopleNovartis2 peopleKite Pharma2 peopleModulo Bio1 peopleKailera Therapeutics1 peopleRevolution Medicines1 people5AM Ventures1 peopleSundance Biosciences1 peopleWestlake BioPartner…1 peopleRonald McDonald Hou…1 people
Data by CrustdataCrustdata

Most common previous employers of Latigo Biotherapeutics, Inc. staff: Amgen (9), Kinnate Biopharma (6), AtaiBeckley (3), PaxVax (3), Gilead Sciences (3), Rho (3). Former Latigo Biotherapeutics, Inc. employees most often moved to Kite Pharma (2), Modulo Bio (1), Kailera Therapeutics (1), Revolution Medicines (1), 5AM Ventures (1), Sundance Biosciences (1).

Web traffic

latigobio.com monthly visitors+26% month over month
1,3433,8266,3085,385202420252026
Data by CrustdataCrustdata

Traffic mix: 0% direct, 0% search, 0% social, 0% paid.

What this company is made of

Headcount by skillwhat people list on their profiles
BBiotechnology
25
PPharmaceutics
24
LLife Sciences
19
CClinical Trials
17
DDrug Development
17
CClinical Development
16
DDrug Discovery
16
CClinical Research
15
OOncology
14
PProject Management
14
Data by CrustdataCrustdata

Most common skills at Latigo Biotherapeutics, Inc.: Biotechnology (25), Pharmaceutics (24), Life Sciences (19), Clinical Trials (17), Drug Development (17), Clinical Development (16), Drug Discovery (16), Clinical Research (15).

Where the team actually sits

Headcount by regionHQ: Thousand Oaks, California, United States
CCalifornia, United States
28
LLos Angeles Metropolitan Area
5
UUnited States
3
SSan Francisco Bay Area
3
NNorth Carolina, United States
3
GGreater Chicago Area
1
RRaleigh-Durham-Chapel Hill Area
1
GGreater Birmingham, Alabama Area
1
Data by CrustdataCrustdata

Latigo Biotherapeutics, Inc. people are concentrated in California, United States (28), Los Angeles Metropolitan Area (5), United States (3), San Francisco Bay Area (3).

Search footprint

Organic clicks
186
per month
Traffic worth
$1K
if bought as ads
Ranking keywords
131

Latigo Biotherapeutics, Inc. attracts about 186 organic search visits a month, traffic worth roughly $1K a month if bought through ads. It gained 11 ranking keywords and lost 17 in the last period.

Frequently asked

How many employees does Latigo Biotherapeutics, Inc. have?

Latigo Biotherapeutics, Inc. has 62 employees as of September 2026.

How much has Latigo Biotherapeutics, Inc. raised?

Latigo Biotherapeutics, Inc. has raised $300M in total, most recently a Series B round in March 2025.

Who is the CEO of Latigo Biotherapeutics, Inc.?

Nima Farzan (Chief Executive Officer) sits at the top of Latigo Biotherapeutics, Inc.'s reporting structure, with 3 direct reports.

Where does Latigo Biotherapeutics, Inc. hire from?

The most common previous employers of current Latigo Biotherapeutics, Inc. staff are Amgen (9 people), Kinnate Biopharma (6 people), AtaiBeckley (3 people).

Where do Latigo Biotherapeutics, Inc. employees go after leaving?

Former Latigo Biotherapeutics, Inc. employees most often move to Kite Pharma (2), Modulo Bio (1), Kailera Therapeutics (1).

How much traffic does Latigo Biotherapeutics, Inc. get from search?

Latigo Biotherapeutics, Inc. attracts about 186 organic search visits a month, worth roughly $1K a month in equivalent ad spend.

What skills do people at Latigo Biotherapeutics, Inc. have?

The most common skills among Latigo Biotherapeutics, Inc. staff are Biotechnology, Pharmaceutics, Life Sciences, Clinical Trials, Drug Development.

Where is Latigo Biotherapeutics, Inc.'s team located?

Latigo Biotherapeutics, Inc. staff are concentrated in California, United States (28), Los Angeles Metropolitan Area (5), United States (3).

How big is Latigo Biotherapeutics, Inc.'s research team?

Latigo Biotherapeutics, Inc. has about 21 people in Research, up 17% over the past year, as of September 2026.

How big is Latigo Biotherapeutics, Inc.'s business development team?

Latigo Biotherapeutics, Inc. has about 13 people in Business Development, up 63% over the past year, as of September 2026.

Computed from 47 current and 19 former Latigo Biotherapeutics, Inc. profiles, as of September 2026. Source: Crustdata.

Build this for any company

Every number on this page came from the Crustdata API. Point the MCP at a company and get the same org chart, alumni list and talent flow in one prompt.

See it Live in ActionRead the API docs